相关实验视频

Updated: Jan 18, 2026

Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition

Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition

Published on: March 11, 2021

重辐射:标准,挑战和针对不同瘤类型的患者专注的策略

Arnaud Beddok^1,2,3, Jonas Willmann^4,5, Anna Embring^6,7

¹Department of Radiation Oncology, Institut Godinot, Reims, France.

CA: a cancer journal for clinicians

|May 29, 2025

概括

再辐射 (reRT) 提供了复发癌症的潜力,但也带有风险. 仔细的患者选择,先进的成像和多学科合作是优化结果和管理副作用的关键.

科学领域:

在瘤学瘤学.
辐射瘤学辐射瘤学
医学物理医学物理

背景情况:

重辐射 (reRT) 是针对局部或区域性复发癌症的一种不断发展的策略.
辐射治疗技术的进步提高了reRT的精度.
在实质性风险的同时,reRT具有显著的潜力.

研究的目的:

探索复发性癌症再辐射的不断发展的治疗策略.
要突出reRT的潜在好处和风险之间的平衡.
讨论优化reRT结果的重要因素.

主要方法:

审查当前的reRT技术,包括强度调制和立体的身体辐射疗法.
强调先进的成像模式,以准确诊断和定位.
整合全身疗法和标准化指导方针.

主要成果:

患者的选择至关重要,考虑到瘤特征,之前治疗以来的时间和组织耐受性.
先进的成像技术有助于区分复发,改进目标,并最大限度地减少健康组织的暴露.
综合系统性治疗和reRT显示出有希望的结果,但需要谨慎管理.

结论:

优化reRT需要仔细的患者选择,先进的成像和多学科的合作.
标准化的指导方针和持续的研究对于一致的报告和决策至关重要.
像质子疗法这样的创新技术可能会进一步提高reRT的安全性和有效性.

关键词:

通过先进的成像技术,实现了先进的成像技术.决策能力决策能力地方区域性复发情况辐射瘤学辐射瘤学再辐射再辐射的方法

更多相关视频

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy

Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy

Published on: June 7, 2015

相关概念视频

Treatment Resistant Cancers

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Cancer Therapies

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...